UV Germi SA
F:1NY

Watchlist Manager
UV Germi SA Logo
UV Germi SA
F:1NY
Watchlist
Price: 2.41 EUR Market Closed
Market Cap: €7.7m

Wall St Price Targets

1NY Price Targets Summary
UV Germi SA

There are no price targets for 1NY.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
UV Germi SA Competitors:
Price Targets
PPG
PPG Industries Inc
14% Upside
BKS
Beeks Financial Cloud Group PLC
56% Upside
SPA
Siam Wellness Group PCL
46% Upside

Revenue
Forecast

8% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-22%
Average Miss
8% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-22%
Average Miss

Over the last 9 years, the compound annual growth rate for Revenue has been 8%.

Gross Profit
Forecast

14% / Year
Past Growth
25% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
14% / Year
Past Growth
25% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 9 years, the compound annual growth rate for Gross Profit has been 14%. The projected CAGR for the next 2 years is 25%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-65%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-65%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for UV Germi SA

Net Income
Forecast

N/A
Past Growth
8% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
8% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Net Income over the next 2 years is 8%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 1NY's stock price target?
Not Available

1NY does not have any price targets made by Wall Street professionals.

What is the Gross Profit forecast for UV Germi SA?
Projected CAGR
25%

Over the last 9 years, the compound annual growth rate for Gross Profit has been 14%. The projected CAGR for the next 2 years is 25%.

What is the Net Income forecast for UV Germi SA?
Projected CAGR
8%

The compound annual growth rate for Net Income over the next 2 years is 8%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett